~~<i id='92326C5D72'><strike id='92326C5D72'><tt id='92326C5D72'><pre id='92326C5D72'></pre></tt></strike></i>~~

Home» leisure time» leisure time

leisure time

author：comprehensive 2025-09-30 10:25:34 Page View：42877

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Awakening the world to the whoosh: A patient's crusade
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

explore

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

A new crop of companies is reshaping the health data economy

AdobeItisoneofhealthcare’smostvexingquandaries:Patientdatamustbesharedtodevelopmoreeffectivemedicine

Moonlake's readout produced a cash windfall. Risks remain

MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

'Investigate these claims': UFO transparency at center of House hearing

3:47RyanGraves,DavidGrusch,andDavidFravorattendtheHouseOversight&AccountabilityCommittee'sNationalSe